FDA approves bictegravir and lenacapavir for HIV - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA approves bictegravir and lenacapavir for HIV

The treatment was evaluated in patients receiving complex antiretroviral regimens.

  • By

  • Kathryn Wighton

  • August 28, 2026

  • 2 min

Share

Original Source(s)

FDA approves bictegravir and lenacapavir for HIV

  • by Kathryn Wighton

  • August 28, 2026

Related Content

Tennessee's Ivermectin Experiment

Pharmacies expand access as oversight questions grow.

Does Sedative Choice Shape Later Cognition?

Researchers examined long-term cognitive outcomes among children who received ICU sedation for acute respiratory failure.

Top 10 CDC Updates Physicians Should Know

Recent CDC advisories, testing updates, and immunization recommendations highlight developments in infectious diseases, immunization, and diagnostic testing relevant to physicians across multiple specialties.